{"id":"W4412984585","doi":"10.1182/bloodadvances.2025016949","title":"Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); Princess Margaret Cancer Centre","funders":"Genentech; Servier; Regeneron Pharmaceuticals; Cilag; Astellas Pharma; Alexion Pharmaceuticals; Seagen; Gilead Sciences; BeiGene; Sanofi; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Tolerability; Adverse effect; Dosing; Photophobia; Refractory (planetary science); Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01342987,0.0005382726,0.001434728,0.0002873665,0.0002750338,0.0008382353,0.0007017694,0.000843334,0.002273941],"category_scores_gemma":[0.008251817,0.0002736635,0.00228366,0.000352596,0.0004182762,0.001080707,0.0003657983,0.001869895,0.0003895119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006857096,"about_ca_system_score_gemma":0.0008454488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002142233,"about_ca_topic_score_gemma":0.0007650305,"domain_scores_codex":[0.9911278,0.00653164,0.00102014,0.0004866617,0.0005525729,0.0002811481],"domain_scores_gemma":[0.9964339,0.001779021,0.001022841,0.0003042975,0.0002444467,0.0002154841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7339525,0.008926269,0.01225449,0.00358782,0.009079782,0.00008929503,0.0003602237,0.003031691,0.01323061,0.0009431539,0.002870049,0.2116742],"study_design_scores_gemma":[0.6305282,0.2877961,0.04681544,0.0005891132,0.00523604,0.0002947711,0.0001218288,0.004312842,0.007766815,0.001529297,0.014904,0.0001056943],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9689473,0.01455397,0.002623747,0.0008960702,0.0002880104,0.006212194,0.001070147,0.0001226407,0.00528598],"genre_scores_gemma":[0.9879632,0.0009821387,0.003487685,0.0005488487,0.0001002625,0.005518506,0.0005150826,0.00002226635,0.0008619751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01342987,"threshold_uncertainty_score":0.07102478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0425052666653595,"score_gpt":0.3572799157750413,"score_spread":0.3147746491096818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}